The role of CCL5 in breast cancer progression and metastasis has been established: this includes upregulation of MMP secretion, pro-tumor effects by generating MDSC in the bone marrow, and a reduction in metastasis when low levels of CCL5 are expressed [67–70]. The gene discussed is CCL5; the disease is breast carcinoma.